Reloxin approved by FDA (Dysport in Europe) - Botox alternative

Jun 13, 2009 @ 03:25 PM — by Dr. Sutton Graham

An alternative to Botox will be available later in 2009. Medicis Corporation, which markets Restylane and Perlane as well as other dermatologic products, announced recently that the FDA has approved its application to market an alternative botulinum toxin in the USA. Medicis has licensed the product known as Dysport in Europe from Ipsen Corporation there.

The new toxin Reloxin will work similarly to BotoxCosmetic, but with different dosages due to different activity of the product. Doctors will need to evaluate its effects on patients and adapt correct dosages.

Dr. Graham has been aware of this alternative neurotoxin for many years due to it's overseas use, and will evaluate it's benefits and risks for our patients when available here. We are one of the most active Botox users in the area, and will certainly offer proven benefits to our patients.

For a press announcement see
For more information on our practice and botulinum toxin see

We hope Reloxin will be a less expensive alternative to Botox!

Comments (0)

Public comments are closed.